Please ENTER to search

← Back

Febuxostat

Detailed information about Febuxostat

CAS Number

144060-53-7

Category

Xanthine oxidase inhibitor

Regulatory Status

Not Yet Filed regulatory_status

CEP/EDMF

EDMF Available

Innovator Brand

Adenuric, Uloric

Therapeutic Area

Gout

USDMF

Others

Febuxostat

Mechanism of Action

Febuxostat is a xanthine oxidase inhibitor. It works by decreasing the amount of uric acid produced by the body. Uric acid buildup can lead to gout or kidney stones.

Uses

Febuxostat is used to treat gout and prevent acute gout attacks. It is also used for the treatment of hyperuricemia (excess of uric acid in the blood) in patients with tumor lysis syndrome.

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer's risk.

Footer Form Banner

Ready to discuss your needs with us?

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

Please enter a valid name (only alphabets and spaces allowed).
Please enter your organization name.
Please enter a valid work email address.
Please enter a valid phone number.
Please select your country.
Please enter your message.
You must agree to the privacy policy.